Roche · 8 hours ago
2026 Summer Intern - Patient Centered-Outcomes Research in Data Sciences and Analytics
Roche is a leading biotechnology company, and they are seeking a Summer Intern for their Patient-Centered Outcomes Research team. The role involves assessing questionnaire robustness and developing guidelines for psychometric screening using Large Language Models, as well as validating the LLM's utility for clinical trial planning.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Develop experience in statistical analysis of clinical trial data
Apply LLM to clinical trial data
Learn about the role of data sciences in drug development
Qualification
Required
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Required Majors: Statistics/Biostatistics, Psychometrics, Biomedical Informatics, and related fields
Understanding of statistical methods
Experience in Working knowledge of programming in R, and version control systems like Git
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Basic knowledge of psychological measurement methods or Quality-of-Life research is desirable
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
Company data provided by crunchbase